Marina Pizzi Selected Research

Synapsins (Synapsin I)

12/2022	Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates.
1/2022	Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype.
11/2021	An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders.
10/2018	Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
7/2015	α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina Pizzi Research Topics

Disease

16	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2015
9	Brain Ischemia (Cerebral Ischemia) 11/2020 - 12/2006
8	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024 - 09/2002
7	Inflammation (Inflammations) 01/2022 - 01/2016
6	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 04/2006
5	Stroke (Strokes) 12/2020 - 01/2009
5	Brain Injuries (Brain Injury) 11/2020 - 01/2009
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2020 - 02/2009
4	Neuroinflammatory Diseases 01/2023 - 04/2014
4	Nerve Degeneration 10/2018 - 07/2015
3	Nervous System Diseases (Neurological Disorders) 02/2024 - 09/2006
3	Synucleinopathies 01/2021 - 01/2017
3	Infarction (Infarctions) 11/2020 - 01/2013
3	Movement Disorders (Movement Disorder) 01/2019 - 01/2017
3	Ischemic Stroke 01/2018 - 02/2009
3	Ischemia 02/2009 - 01/2009
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 09/2002
2	Disease Progression 01/2021 - 02/2016
2	Memory Disorders (Memory Loss) 04/2014 - 01/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Hyperglycemia 01/2022
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2022
1	Constipation 01/2022
1	Anosmia 01/2022
1	Mental Disorders (Mental Disorder) 11/2021
1	Lewy Body Disease (Lewy Body Dementia) 01/2021
1	Hemorrhagic Stroke 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Dementia (Dementias) 11/2018
1	Necrosis 01/2017
1	Amyloid Plaque 01/2017

Drug/Important Bio-Agent (IBA)

16	SynucleinsIBA 02/2024 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2006
7	NF-kappa B (NF-kB)IBA 11/2020 - 09/2006
5	Amyloid (Amyloid Fibrils)IBA 02/2024 - 01/2011
5	Synapsins (Synapsin I)IBA 12/2022 - 07/2015
5	Histones (Histone)IBA 01/2022 - 01/2013
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2015
4	ResveratrolIBA 01/2022 - 01/2013
4	Oxygen (Dioxygen)IBA 11/2020 - 01/2012
4	1- (3',4'- dichloro- 2- fluoro(1,1'- biphenyl)- 4- yl)cyclopropanecarboxylic acidIBA 01/2017 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2009
3	alpha-SynucleinIBA 01/2022 - 01/2015
3	entinostat (MS 275)IBA 11/2020 - 01/2013
3	Sirtuin 1IBA 11/2020 - 01/2013
3	CytokinesIBA 01/2017 - 01/2016
3	IronIBA 01/2017 - 01/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2022 - 01/2022
2	PolyphenolsIBA 12/2020 - 02/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 02/2004
2	EnzymesIBA 01/2016 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2012 - 02/2009
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2011 - 01/2011
2	LeptinIBA 02/2009 - 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Methylphenidate (Ritalin)FDA LinkGeneric 12/2022
1	Proto-Oncogene Proteins c-relIBA 01/2022
1	Advanced Glycation End ProductsIBA 01/2022
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2022
1	carbazoleIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Cystatin CIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 11/2020
1	Thioctic Acid (Lipoic Acid)IBA 02/2019
1	Amino Acids FDA Link 02/2019
1	VitaminsIBA 02/2019
1	MicronutrientsIBA 02/2019
1	Protein AggregatesIBA 01/2019
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2018
1	AMP-Activated Protein KinasesIBA 01/2018
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2018
1	Cytochromes c (Cytochrome c)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2017
1	ArginaseIBA 01/2017
1	IgG Receptors (Fc gamma RI)IBA 01/2017
1	CalciumIBA 01/2017
1	ChitinasesIBA 01/2017
1	Mannose ReceptorIBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	PrionsIBA 01/2017
1	FlavonoidsIBA 10/2016
1	LuteolinIBA 10/2016
1	palmidrolIBA 10/2016
1	AmidesIBA 10/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2016
1	N-acylethanolaminesIBA 10/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	LipidsIBA 01/2016
1	ChemokinesIBA 01/2016
1	ChromatinIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016

Therapy/Procedure

5	Therapeutics 12/2022 - 09/2002
1	Ligation 05/2018